Skip to main content

Table 6 Comparison between pre-treatment SUV, post-treatment SUV, and % change in SUV (∆SUV) of the PD, SD, and PR groups

From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma

  Progressive disease Stable disease Partial response P-value
Pre-treatment SUV
 Median 4 14.3 13.9  
 IQR 3.63–8.8 9.43–25.78 11.7–16.05 0.09
 Range 3.5–10.4 3.5–34.7 10–19.19  
Post-treatment SUV
 Median 8.1 15.4 6  
 IQR 7.13–18.68 5.6–18.18 4.56–6.38 0.085
 Range 6.8–22.0 2–28.2 1.1–8.0  
∆SUV
 Median 102.5 −18.7 −57.5  
 IQR 96.35–110.75 −44.23 to 7.43 −75.0 to −51.7 0.0008
 Range 94.3–113.5 −54 to 15.4 −88.9 to −48.3